In a filing, Teva- Pharmaceutical Industries Ltd. ADR revealed its EVP, Chief Financial Officer Kalif Eliyahu Sharon unloaded Company’s shares for reported $1.05 million on Mar 06 ’24. In the deal valued at $13.52 per share,77,550 shares were sold. As a result of this transaction, Kalif Eliyahu Sharon now holds 203,691 shares worth roughly $2.9 million.
Then, Sabag Mark sold 100,000 shares, generating $1,352,090 in total proceeds. Upon selling the shares at $13.52, the EVP, International Markets now owns 382,590 shares.
Before that, Daniell Richard sold 48,629 shares. Teva- Pharmaceutical Industries Ltd. ADR shares valued at $657,240 were divested by the Exec. VP, European Commercial at a price of $13.52 per share. As a result of the transaction, Daniell Richard now holds 69,770 shares, worth roughly $0.99 million.
JP Morgan upgraded its Teva- Pharmaceutical Industries Ltd. ADR [TEVA] rating to a Neutral from a an Underweight in a research note published recently. A number of analysts have revised their coverage, including Piper Sandler’s analysts, who increased its forecast for the stock in mid February from “a Neutral” to “an Overweight”. Jefferies also remained covering TEVA and has increased its forecast on January 23, 2024 with a “Buy” recommendation from previously “Hold” rating. Piper Sandler revised its rating on January 03, 2024. It rated TEVA as “a Neutral” which previously was an “an Underweight”.
Price Performance Review of TEVA
On Friday, Teva- Pharmaceutical Industries Ltd. ADR [NYSE:TEVA] saw its stock jump 2.30% to $14.25. Over the last five days, the stock has gained 0.99%. Teva- Pharmaceutical Industries Ltd. ADR shares have risen nearly 36.49% since the year began. Nevertheless, the stocks have risen 56.59% over the past one year. While a 52-week high of $14.45 was reached on 03/27/24, a 52-week low of $7.09 was recorded on 01/02/24. SMA at 50 days reached $13.17, while 200 days put it at $10.37. A total of 9.24 million shares were traded, compared to the trading of 8.61 million shares in the previous session.
Levels Of Support And Resistance For TEVA Stock
The 24-hour chart illustrates a support level at 14.02, which if violated will result in even more drops to 13.80. On the upside, there is a resistance level at 14.40. A further resistance level may holdings at 14.55. The Relative Strength Index (RSI) on the 14-day chart is 62.84, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.20, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 15.62%. Stochastics %K at 72.66% indicates the stock is a holding.
How much short interest is there in Teva- Pharmaceutical Industries Ltd. ADR?
A steep rise in short interest was recorded in Teva- Pharmaceutical Industries Ltd. ADR stocks on Mar 15, 2024, dropping by -4.93 million shares to a total of 10.46 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 15.39 million shares. There was a decline of -47.13%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on December 18, 2023 when HSBC Securities began covering the stock and recommended ‘”a Buy”‘ rating along with a $13 price target.
